Breaking News
This Will Piss You Off!
This GENIUS Trellis Trick Grows MORE Cucumbers with LESS Effort
MOLD FREE COFFEE?! From Bean to Brew: Unlocking Pure Coffee Bliss with Lore Coffee Roasters
Boots on the Ground...15 viewers share the good and bad of the US economy.
Top Tech News
Hydrogen Gas Blend Will Reduce Power Plant's Emissions by 75% - as it Helps Power 6 States
The Rise & Fall of Dome Houses: Buckminster Fuller's Geodesic Domes & Dymaxion
New AI data centers will use the same electricity as 2 million homes
Is All of This Self-Monitoring Making Us Paranoid?
Cavorite X7 makes history with first fan-in-wing transition flight
Laser-powered fusion experiment more than doubles its power output
Watch: Jetson's One Aircraft Just Competed in the First eVTOL Race
Cab-less truck glider leaps autonomously between road and rail
Can Tesla DOJO Chips Pass Nvidia GPUs?
Iron-fortified lumber could be a greener alternative to steel beams
DARPA Nucleic Technology Funded to Get Virus Response to 1-60 Days
The P3 teams are developing technologies to deliver antibodies using nucleic acid technology, and achieve sufficient serum concentrations of the antibodies for protection against the pathogen within three days after administration.
DARPA has programs for Pandemic Prevention Platform, Nucleic Acids On-Demand Worldwide (NOW), and PReemptive Expression of Protective Alleles and Response Elements (PREPARE) programs.
Nucleic Acids On-Demand Worldwide (NOW)
The goal of the NOW program is to develop a mobile medical countermeasure (MCM) manufacturing platform for use in stabilization and humanitarian operations to produce, formulate, and package hundreds of doses of nucleic acid therapeutics (DNA and/or RNA) in less than 24 hours. The developed platform should be a resilient, mobile, readily accessible nucleic acid MCM manufacturing capability that enables immediate threat response anywhere the military operates with minimal user intervention.